LXRX vs. SPY
Compare and contrast key facts about Lexicon Pharmaceuticals, Inc. (LXRX) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LXRX or SPY.
Correlation
The correlation between LXRX and SPY is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
LXRX vs. SPY - Performance Comparison
Key characteristics
LXRX:
-0.72
SPY:
1.97
LXRX:
-1.09
SPY:
2.64
LXRX:
0.87
SPY:
1.36
LXRX:
-0.73
SPY:
2.97
LXRX:
-1.28
SPY:
12.34
LXRX:
57.26%
SPY:
2.03%
LXRX:
100.55%
SPY:
12.68%
LXRX:
-99.80%
SPY:
-55.19%
LXRX:
-99.76%
SPY:
-0.01%
Returns By Period
In the year-to-date period, LXRX achieves a 6.28% return, which is significantly higher than SPY's 4.03% return. Over the past 10 years, LXRX has underperformed SPY with an annualized return of -18.90%, while SPY has yielded a comparatively higher 13.24% annualized return.
LXRX
6.28%
13.75%
-52.72%
-75.32%
-22.96%
-18.90%
SPY
4.03%
2.03%
10.70%
23.63%
14.37%
13.24%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
LXRX vs. SPY — Risk-Adjusted Performance Rank
LXRX
SPY
LXRX vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Lexicon Pharmaceuticals, Inc. (LXRX) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
LXRX vs. SPY - Dividend Comparison
LXRX has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.16%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LXRX Lexicon Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.16% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
LXRX vs. SPY - Drawdown Comparison
The maximum LXRX drawdown since its inception was -99.80%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for LXRX and SPY. For additional features, visit the drawdowns tool.
Volatility
LXRX vs. SPY - Volatility Comparison
Lexicon Pharmaceuticals, Inc. (LXRX) has a higher volatility of 29.37% compared to SPDR S&P 500 ETF (SPY) at 3.15%. This indicates that LXRX's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.